Thomas J. Carty - Concepedia

Author

Thomas J. Carty

Also Known As

Carty, T.J., T J Carty, T. Carty, T. J. CARTY, T. J. Carty, T.J. Carty, THOMAS J. CARTY, Thomas (Thomas Joseph) Carty, Thomas Carty, Thomas J Carty

Publications

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Brandeis University Tufts University Tufts Medical Center

About

Thomas J. Carty is an author at Pfizer (United States) specializing in pharmacology, medicine, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	21	845
2	Natural Sciences	9	9	419
3	Engineering	4	4	147
4	Health Sciences	2	2	98
5	Allergy	1	1	37

Thomas J. Carty

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase Catherine E. Trebino, Jeffrey L. Stock, Colleen P. Gibbons, Proceedings of the National Academy of Sciences	2003	541
IL-1 beta maturation: evidence that mature cytokine formation can be induced specifically by nigericin David G. Perregaux, J Barberia, Anthony J. Lanzetti, The Journal of Immunology	1992	133
Redirection of Eicosanoid Metabolism in mPGES-1-deficient Macrophages Catherine E. Trebino, James D. Eskra, Timothy S. Wachtmann, Journal of Biological Chemistry	2005	90
Effect of Methylmalonyl Coenzyme A, a Metabolite Which Accumulates in Vitamin B12 Deficiency, on Fatty Acid Synthesis George J. Cardinale, Thomas J. Carty, Robert H. Abeles Journal of Biological Chemistry Metabolomic ProfilingMetabolic SyndromeFatty AcidsFatty Acid SynthesisVitamin B12 Deficiency	1970	85
Theoretical and Experimental Design of Atypical Kinase Inhibitors: Application to p38 MAP Kinase Kim F. McClure, Yuriy A. Abramov, Ellen R. Laird, Journal of Medicinal Chemistry Atypical Kinase InhibitorsDrug TargetP38 KinaseP38 InhibitorsPharmacotherapy	2005	79
Synthesis and biological activity of selective pipecolic acid-based TNF-α converting enzyme (TACE) inhibitors Michael A. Letavic, Matt Z. Axt, John T. Barberia, Bioorganic & Medicinal Chemistry Letters Biological ActivityBiochemistryNatural SciencesMedicineDrug Development	2002	75
Piroxicam, a potent inhibitor of prostaglandin production in cell culture. Structure-activity study Thomas J. Carty, James D. Eskra, Joseph G. Lombardino, Prostaglandins Molecular PharmacologyPharmaceutical ScienceBiochemistryStructure-activity StudyMedicine	1980	70
Piroxicam, a structurally novel anti-inflammatory compound. Mode of prostaglandin synthesis inhibition Thomas J. Carty, Joann S Stevens, Joseph G. Lombardino, Prostaglandins InflammationMolecular PharmacologyPharmaceutical ScienceAnti-inflammatoryMedicine	1980	67
Tranylcypromine and 15-hydroperoxyarachidonate affect arachidonic acid release in addition to inhibition of prostacyclin synthesis in calf aortic endothelial cells. S L Hong, Thomas J. Carty, Daniel Deykin Journal of Biological Chemistry	1980	64
Inhibition of 5‐lipoxygenase product formation and polymorphonuclear cell degranulation by tenidap sodium in patients with rheumatoid arthritis Warren D. Blackburn, Louis W. Heck, Leland D. Loose, Arthritis & Rheumatism	1991	56

Page 1